# Tivozanib Before Surgery in Treating Patients With Localized Kidney Cancer

> **NCT01769885** · NA · WITHDRAWN · sponsor: **Roswell Park Cancer Institute**

## Conditions studied

- Stage II Renal Cell Cancer
- Stage III Renal Cell Cancer

## Interventions

- **DRUG:** tivozanib
- **PROCEDURE:** therapeutic conventional surgery

## Key facts

- **NCT ID:** NCT01769885
- **Lead sponsor:** Roswell Park Cancer Institute
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** WITHDRAWN
- **Start date:** 2013-03-14
- **Primary completion:** 2013-06-14
- **Final completion:** 2013-12-02
- **Target enrollment:** 0 (ACTUAL)
- **Last updated:** 2022-08-15

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01769885

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01769885, "Tivozanib Before Surgery in Treating Patients With Localized Kidney Cancer". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT01769885. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*